Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Surface Layer of Lactobacillus helveticus MIMLh5 Promotes Endocytosis by Dendritic Cells.

Taverniti V, Marengo M, Fuglsang E, Skovsted HM, Arioli S, Mantegazza G, Gargari G, Iametti S, Bonomi F, Guglielmetti S, Frøkiær H.

Appl Environ Microbiol. 2019 Apr 18;85(9). pii: e00138-19. doi: 10.1128/AEM.00138-19. Print 2019 May 1.

2.

Effect of Cell Concentration on the Persistence in the Human Intestine of Four Probiotic Strains Administered through a Multispecies Formulation.

Taverniti V, Koirala R, Dalla Via A, Gargari G, Leonardis E, Arioli S, Guglielmetti S.

Nutrients. 2019 Jan 29;11(2). pii: E285. doi: 10.3390/nu11020285.

3.

Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells.

Burrello C, Garavaglia F, Cribiù FM, Ercoli G, Lopez G, Troisi J, Colucci A, Guglietta S, Carloni S, Guglielmetti S, Taverniti V, Nizzoli G, Bosari S, Caprioli F, Rescigno M, Facciotti F.

Nat Commun. 2018 Dec 5;9(1):5184. doi: 10.1038/s41467-018-07359-8.

4.

Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults.

Arioli S, Koirala R, Taverniti V, Fiore W, Guglielmetti S.

Front Microbiol. 2018 Aug 2;9:1720. doi: 10.3389/fmicb.2018.01720. eCollection 2018.

5.

Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial.

Cremon C, Guglielmetti S, Gargari G, Taverniti V, Castellazzi AM, Valsecchi C, Tagliacarne C, Fiore W, Bellini M, Bertani L, Gambaccini D, Cicala M, Germanà B, Vecchi M, Pagano I, Barbaro MR, Bellacosa L, Stanghellini V, Barbara G.

United European Gastroenterol J. 2018 May;6(4):604-613. doi: 10.1177/2050640617736478. Epub 2017 Oct 8.

6.

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.

Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S.

Environ Microbiol. 2018 Sep;20(9):3201-3213. doi: 10.1111/1462-2920.14271. Epub 2018 Sep 24.

7.

Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake.

Gargari G, Deon V, Taverniti V, Gardana C, Denina M, Riso P, Guardamagna O, Guglielmetti S.

FEMS Microbiol Ecol. 2018 May 1;94(5). doi: 10.1093/femsec/fiy045.

8.

A unique surface on Pat1 C-terminal domain directly interacts with Dcp2 decapping enzyme and Xrn1 5'-3' mRNA exonuclease in yeast.

Charenton C, Gaudon-Plesse C, Fourati Z, Taverniti V, Back R, Kolesnikova O, Séraphin B, Graille M.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9493-E9501. doi: 10.1073/pnas.1711680114. Epub 2017 Oct 24.

9.

In vitro assessment of the ability of probiotics, blueberry and food carbohydrates to prevent S. pyogenes adhesion on pharyngeal epithelium and modulate immune responses.

Taverniti V, Dalla Via A, Minuzzo M, Del Bo' C, Riso P, Frøkiær H, Guglielmetti S.

Food Funct. 2017 Oct 18;8(10):3601-3609. doi: 10.1039/c7fo00829e.

10.

Heme-oxygenase-1 Production by Intestinal CX3CR1+ Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis.

Marelli G, Erreni M, Anselmo A, Taverniti V, Guglielmetti S, Mantovani A, Allavena P.

Cancer Res. 2017 Aug 15;77(16):4472-4485. doi: 10.1158/0008-5472.CAN-16-2501. Epub 2017 Jun 15.

11.

A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells.

Balzaretti S, Taverniti V, Guglielmetti S, Fiore W, Minuzzo M, Ngo HN, Ngere JB, Sadiq S, Humphreys PN, Laws AP.

Appl Environ Microbiol. 2017 Jan 17;83(3). pii: e02702-16. doi: 10.1128/AEM.02702-16. Print 2017 Feb 1.

12.

Structure of the active form of Dcp1-Dcp2 decapping enzyme bound to m7GDP and its Edc3 activator.

Charenton C, Taverniti V, Gaudon-Plesse C, Back R, Séraphin B, Graille M.

Nat Struct Mol Biol. 2016 Nov;23(11):982-986. doi: 10.1038/nsmb.3300. Epub 2016 Oct 3.

PMID:
27694841
13.

Myeloid cell expressed proprotein convertase FURIN attenuates inflammation.

Cordova ZM, Grönholm A, Kytölä V, Taverniti V, Hämäläinen S, Aittomäki S, Niininen W, Junttila I, Ylipää A, Nykter M, Pesu M.

Oncotarget. 2016 Aug 23;7(34):54392-54404. doi: 10.18632/oncotarget.11106.

14.

Structural basis for tRNA modification by Elp3 from Dehalococcoides mccartyi.

Glatt S, Zabel R, Kolaj-Robin O, Onuma OF, Baudin F, Graziadei A, Taverniti V, Lin TY, Baymann F, Seraphin B, Breunig KD, Müller CW.

Nat Struct Mol Biol. 2016 Sep;23(9):794-802. doi: 10.1038/nsmb.3265. Epub 2016 Jul 25.

15.

Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults.

Gargari G, Taverniti V, Balzaretti S, Ferrario C, Gardana C, Simonetti P, Guglielmetti S.

Appl Environ Microbiol. 2016 Sep 16;82(19):5850-9. doi: 10.1128/AEM.01753-16. Print 2016 Oct 1.

16.

Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects.

Rigoni R, Fontana E, Guglielmetti S, Fosso B, D'Erchia AM, Maina V, Taverniti V, Castiello MC, Mantero S, Pacchiana G, Musio S, Pedotti R, Selmi C, Mora JR, Pesole G, Vezzoni P, Poliani PL, Grassi F, Villa A, Cassani B.

J Exp Med. 2016 Mar 7;213(3):355-75. doi: 10.1084/jem.20151116. Epub 2016 Feb 29.

17.

Gbp2 interacts with THO/TREX through a novel type of RRM domain.

Martínez-Lumbreras S, Taverniti V, Zorrilla S, Séraphin B, Pérez-Cañadillas JM.

Nucleic Acids Res. 2016 Jan 8;44(1):437-48. doi: 10.1093/nar/gkv1303. Epub 2015 Nov 23.

18.

The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration.

Balzaretti S, Taverniti V, Rondini G, Marcolegio G, Minuzzo M, Remagni MC, Fiore W, Arioli S, Guglielmetti S.

Front Microbiol. 2015 Sep 15;6:952. doi: 10.3389/fmicb.2015.00952. eCollection 2015.

19.

Melting curve analysis of a groEL PCR fragment for the rapid genotyping of strains belonging to the Lactobacillus casei group of species.

Koirala R, Taverniti V, Balzaretti S, Ricci G, Fortina MG, Guglielmetti S.

Microbiol Res. 2015 Apr;173:50-8. doi: 10.1016/j.micres.2015.01.001. Epub 2015 Feb 12.

20.

Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects.

Ng CK, Shboul M, Taverniti V, Bonnard C, Lee H, Eskin A, Nelson SF, Al-Raqad M, Altawalbeh S, Séraphin B, Reversade B.

Hum Mol Genet. 2015 Jun 1;24(11):3163-71. doi: 10.1093/hmg/ddv067. Epub 2015 Feb 24.

21.

Elimination of cap structures generated by mRNA decay involves the new scavenger mRNA decapping enzyme Aph1/FHIT together with DcpS.

Taverniti V, Séraphin B.

Nucleic Acids Res. 2015 Jan;43(1):482-92. doi: 10.1093/nar/gku1251. Epub 2014 Nov 28.

22.

Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults.

Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, Stuknyte M, Chouaia B, Riso P, Guglielmetti S.

J Nutr. 2014 Nov;144(11):1787-96. doi: 10.3945/jn.114.197723. Epub 2014 Sep 3. Erratum in: J Nutr. 2015 Apr;145(4):839.

PMID:
25332478
23.

Methodological issues in the study of intestinal microbiota in irritable bowel syndrome.

Taverniti V, Guglielmetti S.

World J Gastroenterol. 2014 Jul 21;20(27):8821-36. doi: 10.3748/wjg.v20.i27.8821. Review.

24.

Immunomodulatory effect of a wild blueberry anthocyanin-rich extract in human Caco-2 intestinal cells.

Taverniti V, Fracassetti D, Del Bo' C, Lanti C, Minuzzo M, Klimis-Zacas D, Riso P, Guglielmetti S.

J Agric Food Chem. 2014 Aug 20;62(33):8346-51. doi: 10.1021/jf502180j. Epub 2014 Aug 8.

25.

TgaA, a VirB1-like component belonging to a putative type IV secretion system of Bifidobacterium bifidum MIMBb75.

Guglielmetti S, Balzaretti S, Taverniti V, Miriani M, Milani C, Scarafoni A, Corona S, Ciranna A, Arioli S, Santala V, Iametti S, Bonomi F, Ventura M, Mora D, Karp M.

Appl Environ Microbiol. 2014 Sep;80(17):5161-9. doi: 10.1128/AEM.01413-14. Epub 2014 Jun 20.

26.

The C-terminal domain from S. cerevisiae Pat1 displays two conserved regions involved in decapping factor recruitment.

Fourati Z, Kolesnikova O, Back R, Keller J, Charenton C, Taverniti V, Plesse CG, Lazar N, Durand D, van Tilbeurgh H, Séraphin B, Graille M.

PLoS One. 2014 May 15;9(5):e96828. doi: 10.1371/journal.pone.0096828. eCollection 2014.

27.

Murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its cysteine- and histidine-dependent amidohydrolase/peptidase (CHAP) amidase domain.

Guglielmetti S, Zanoni I, Balzaretti S, Miriani M, Taverniti V, De Noni I, Presti I, Stuknyte M, Scarafoni A, Arioli S, Iametti S, Bonomi F, Mora D, Karp M, Granucci F.

Appl Environ Microbiol. 2014 Sep;80(17):5170-7. doi: 10.1128/AEM.00761-14. Epub 2014 May 9.

28.

Lactobacillus helveticus MIMLh5-specific antibodies for detection of S-layer protein in Grana Padano protected-designation-of-origin cheese.

Stuknyte M, Brockmann EC, Huovinen T, Guglielmetti S, Mora D, Taverniti V, Arioli S, De Noni I, Lamminmäki U.

Appl Environ Microbiol. 2014 Jan;80(2):694-703. doi: 10.1128/AEM.03057-13. Epub 2013 Nov 15.

29.

Bifidobacterium bifidum PRL2010 modulates the host innate immune response.

Turroni F, Taverniti V, Ruas-Madiedo P, Duranti S, Guglielmetti S, Lugli GA, Gioiosa L, Palanza P, Margolles A, van Sinderen D, Ventura M.

Appl Environ Microbiol. 2014 Jan;80(2):730-40. doi: 10.1128/AEM.03313-13. Epub 2013 Nov 15.

30.

Differential modulation of human intestinal bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) drink.

Guglielmetti S, Fracassetti D, Taverniti V, Del Bo' C, Vendrame S, Klimis-Zacas D, Arioli S, Riso P, Porrini M.

J Agric Food Chem. 2013 Aug 28;61(34):8134-40. doi: 10.1021/jf402495k. Epub 2013 Aug 19.

PMID:
23883473
31.

Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions.

Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sánchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11151-6. doi: 10.1073/pnas.1303897110. Epub 2013 Jun 17.

32.

Luteibacter rhizovicinus MIMR1 promotes root development in barley (Hordeum vulgare L.) under laboratory conditions.

Guglielmetti S, Basilico R, Taverniti V, Arioli S, Piagnani C, Bernacchi A.

World J Microbiol Biotechnol. 2013 Nov;29(11):2025-32. doi: 10.1007/s11274-013-1365-6. Epub 2013 May 8.

33.

S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.

Taverniti V, Stuknyte M, Minuzzo M, Arioli S, De Noni I, Scabiosi C, Cordova ZM, Junttila I, Hämäläinen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S.

Appl Environ Microbiol. 2013 Feb;79(4):1221-31. doi: 10.1128/AEM.03056-12. Epub 2012 Dec 7.

34.

Health-Promoting Properties of Lactobacillus helveticus.

Taverniti V, Guglielmetti S.

Front Microbiol. 2012 Nov 19;3:392. doi: 10.3389/fmicb.2012.00392. eCollection 2012.

35.

In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.

Taverniti V, Minuzzo M, Arioli S, Junttila I, Hämäläinen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S.

Appl Environ Microbiol. 2012 Jun;78(12):4209-16. doi: 10.1128/AEM.00325-12. Epub 2012 Apr 13.

36.

Mycobacterium smegmatis RNase J is a 5'-3' exo-/endoribonuclease and both RNase J and RNase E are involved in ribosomal RNA maturation.

Taverniti V, Forti F, Ghisotti D, Putzer H.

Mol Microbiol. 2011 Dec;82(5):1260-76. doi: 10.1111/j.1365-2958.2011.07888.x. Epub 2011 Nov 3.

37.

The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).

Taverniti V, Guglielmetti S.

Genes Nutr. 2011 Aug;6(3):261-74. doi: 10.1007/s12263-011-0218-x. Epub 2011 Apr 16.

38.

A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response.

Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Zanoni I, Stuknyte M, Granucci F, Karp M, Mora D.

Infect Immun. 2010 Nov;78(11):4734-43. doi: 10.1128/IAI.00559-10. Epub 2010 Aug 23.

39.

Oral bacteria as potential probiotics for the pharyngeal mucosa.

Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D.

Appl Environ Microbiol. 2010 Jun;76(12):3948-58. doi: 10.1128/AEM.00109-10. Epub 2010 Apr 23.

Supplemental Content

Loading ...
Support Center